{"name":"Xiang Guang-da","slug":"xiang-guang-da","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Intensive multifactorial group","genericName":"Intensive multifactorial group","slug":"intensive-multifactorial-group","indication":"Other","status":"phase_2"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"metformin 0.85 twice daily for 6 months","genericName":"metformin 0.85 twice daily for 6 months","slug":"metformin-0-85-twice-daily-for-6-months","indication":"Type 2 diabetes mellitus","status":"marketed"}]}],"pipeline":[{"name":"Intensive multifactorial group","genericName":"Intensive multifactorial group","slug":"intensive-multifactorial-group","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"metformin 0.85 twice daily for 6 months","genericName":"metformin 0.85 twice daily for 6 months","slug":"metformin-0-85-twice-daily-for-6-months","phase":"marketed","mechanism":"Metformin reduces hepatic glucose production and improves insulin sensitivity in peripheral tissues, lowering blood glucose levels in type 2 diabetes.","indications":["Type 2 diabetes mellitus"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPWUJPa0xVMTlyd29hU2tTeWZRMzBvZTgtWG1ESEZoODF4aU0zcDI4WUdEQkRJbzUzM3RlRlRlOVlaUEhVeVN6V1dkR0o1dTB5X0pkLU5rdmRwTzVpR2VDc1E1RDdjOWZyMVRNUW9ZZGRhczlWOHdtQ3lOU3ZRcEtuQUlUN21BTmNlVnFHQ3k1ZEpESHc?oc=5","date":"2025-09-18","type":"pipeline","source":"CEOWORLD magazine","summary":"World’s Richest People 2025: The Top Billionaires Globally - CEOWORLD magazine","headline":"World’s Richest People 2025: The Top Billionaires Globally","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQRnlZcTA4aTFhWkcyV2FWUV9TU3RpQWRuZy1wN0I2OWlndldiazBLSy1VVngzMFU2T2dBcDhFQy0tWDJIcm0tbFBQdWJHbzJ0Vld6N1NleUJEb2RjU09rcFBqZTNBX2dHSmpPTXc0cGdFQzdaZ0VGWFczY0hubWh6akJmbFU5VEkxOUZza3UySGdLVlFkQkhYZDdPTTU1WUpCOFplaTdFX3ZlSWwzaUlCRE9Uekg0SnM?oc=5","date":"2023-06-20","type":"pipeline","source":"Reuters","summary":"LME cancelled nickel trades to 'save' Tsingshan, London court told - Reuters","headline":"LME cancelled nickel trades to 'save' Tsingshan, London court told","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQUEx5LUowWkZFMWhUTDBfZmZtNlpGUXc0a1NBcjNaMFctRjhjR3hhaUV3TEkwUkZ2aGpUT0ZXQk9LRUI0NXJZMG5aQWxEcnlFMTUyRk5ZZXZlMkFYUUg1LUZLNi1lYXNZUnVDc1B0SjZ1a1EwOUZMTmptaG52SWlHSDN5TU9aSzhBYURUQlBnS3ZHVlJqN1dj?oc=5","date":"2023-05-07","type":"pipeline","source":"The Wire China","summary":"The Nickel Pickle - The Wire China","headline":"The Nickel Pickle","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE9MSU9LZTlRVWNtWXZNdUl2enBUMGJQMS0zZ09wbnlSS2JFYm9iT0d1STR5TURyV0cyMk02dXdBOUNlSlhMamdjYkFSS3dIMVgzYUg5UDlMeC1LNDU2emlfU2ExbzVvRXN6ZEE?oc=5","date":"2022-03-20","type":"pipeline","source":"The Wire China","summary":"The Nickel Empire - The Wire China","headline":"The Nickel Empire","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOQWxXbU9nZHZveUY2N0M5eENoVkFQVnBrOFlJWGhQRUpNbW9iandYUm5xWlpYdG9kV0dNcmY2Y1RmVXQ0Ui01MlBSV1BGLXEyT0p3MXZPaHBOb2V6dDNTQ3FXNTRWRC1RSUhENWJKdWt3eDlGOVpiUFlNWC1zQV9HLTVUS1NiQTFvU2V4aTB0M1hoQVc1Y1lCMmpxRGY3LTVxa3BYWXhqbGQydjhVOExaNlowMHdZZw?oc=5","date":"2022-03-13","type":"pipeline","source":"Reuters","summary":"Focus: Chinese tycoon's 'big short' on nickel trips up Tsingshan's miracle growth - Reuters","headline":"Focus: Chinese tycoon's 'big short' on nickel trips up Tsingshan's miracle growth","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}